Authors:
Maeda, S
Kagami, Y
Ogura, M
Taji, H
Suzuki, R
Kondo, E
Asakura, S
Takeuchi, T
Miura, K
Ando, M
Nakamura, S
Ito, T
Kinoshita, T
Ueda, R
Morishima, Y
Citation: S. Maeda et al., CD34(+)-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: Increased riskof infectious complications, INT J HEMAT, 74(2), 2001, pp. 214-221
Authors:
Nakamura, S
Kato, M
Ichimura, K
Yatabe, Y
Kagami, Y
Suzuki, R
Taji, H
Kondo, E
Asakura, S
Kojima, M
Murakami, S
Yamao, K
Tsuzuki, T
Adachi, K
Miwa, A
Yoshida, T
Citation: S. Nakamura et al., Peripheral T/natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases, INT J HEMAT, 73(1), 2001, pp. 108-114
Authors:
Matsuo, K
Suzuki, R
Hamajima, N
Ogura, M
Kagami, Y
Taji, H
Kondoh, E
Maeda, S
Asakura, S
Kaba, S
Nakamura, S
Seto, M
Morishima, Y
Tajima, K
Citation: K. Matsuo et al., Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma, BLOOD, 97(10), 2001, pp. 3205-3209
Authors:
Miyamura, K
Hamaguchi, M
Taji, H
Kanie, T
Kohno, A
Tanimoto, M
Saito, H
Kojima, S
Matsuyama, T
Kitaori, K
Nagafuji, K
Sato, T
Kodera, Y
Citation: K. Miyamura et al., Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors, BONE MAR TR, 25(5), 2000, pp. 545-548
Authors:
Kagami, Y
Sobue, R
Ito, N
Yatabe, Y
Taji, H
Suzuki, R
Seto, M
Ogura, M
Suchi, T
Morishima, Y
Nakamura, S
Citation: Y. Kagami et al., Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8(+) andCD56(-) phenotype, and its relation to Epstein-Barr virus: a report of twocases, INT J HEMAT, 70(2), 1999, pp. 105-111
Authors:
Kasai, M
Akatsuka, Y
Emi, N
Taji, H
Kohno, A
Abe, A
Tanimoto, M
Kodera, Y
Saito, H
Citation: M. Kasai et al., Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1, INT J HEMAT, 69(2), 1999, pp. 112-118
Authors:
Nakamura, S
Nagahama, M
Kagami, Y
Yatabe, Y
Takeuchi, T
Kojima, M
Motoori, T
Suzuki, R
Taji, H
Ogura, M
Mizoguchi, Y
Okamoto, M
Suzuki, H
Oyama, A
Seto, M
Morishima, Y
Koshikawa, T
Takahashi, T
Kurita, S
Suchi, T
Citation: S. Nakamura et al., Hodgkin's disease expressing follicular dendritic cell marker CD21 withoutany other B-cell marker - A clinicopathologic study of nine cases, AM J SURG P, 23(4), 1999, pp. 363-376
Authors:
Kagami, Y
Suzuki, R
Taji, H
Yatabe, Y
Takeuchi, T
Maeda, S
Kondo, E
Kojima, M
Motoori, T
Mizoguchi, Y
Okamoto, M
Ohnishi, K
Yamabe, H
Seto, M
Ogura, M
Koshikawa, T
Takahashi, T
Kurita, S
Morishima, Y
Suchi, T
Nakamura, S
Citation: Y. Kagami et al., Nodal cytotoxic lymphoma spectrum - A clinicopathologic study of 66 patients, AM J SURG P, 23(10), 1999, pp. 1184-1200
Authors:
Murata, M
Nishida, T
Haneda, M
Kanie, T
Taji, H
Iida, H
Suzuki, R
Hamaguchi, M
Minami, S
Kodera, Y
Citation: M. Murata et al., A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantation, BR J HAEM, 105(3), 1999, pp. 799-802